Patents by Inventor Yoshiyuki Moriguchi

Yoshiyuki Moriguchi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Agent for treatment of metabolic bone disease
    Patent number: 7235525
    Abstract: An agent for treatment of metabolic bone disease, which contains EPO as an active ingredient, or a method for treating a patient with metabolic bone disease, which comprises EPO, is provided. Pharmaceutical products containing EPO as the active ingredient are novel prophylactic and therapeutic agents which show an ameliorative action by healing bone and bone marrow lesions in bone disease, especially bone disease based on impaired bone metabolism, aside from the previously reported erythrocyte increasing action of EPO. Pathological states, targeted by these pharmaceutical products, are bone diseases showing metabolic bone disorders, including renal failure-associated osteodystrophy, marble bone disease, diabetic nephropathy, and osteoporosis.
    Type: Grant
    Filed: June 6, 2003
    Date of Patent: June 26, 2007
    Assignee: Chugai Seiyaku Kabushiki Kaisha
    Inventors: Yoshihiro Motomiya, Yoshiyuki Moriguchi, Hiroyuki Ohkawa
  • Remedy for bone mtabolic diseases
    Publication number: 20050176635
    Abstract: An agent for treatment of metabolic bone disease, which contains EPO as an active ingredient, or a method for treating a patient with metabolic bone disease, which comprises EPO, is provided. Pharmaceutical products containing EPO as the active ingredient are novel prophylactic and therapeutic agents which show an ameliorative action by healing bone and bone marrow lesions in bone disease, especially bone disease based on impaired bone metabolism, aside from the previously reported erythrocyte increasing action of EPO. Pathological states, targeted by these pharmaceutical products, are bone diseases showing metabolic bone disorders, including renal failure-associated osteodystrophy, marble bone disease, diabetic nephropathy, and osteoporosis.
    Type: Application
    Filed: June 6, 2003
    Publication date: August 11, 2005
    Applicant: Chugai Seiyaku Kabushiki Kaisha
    Inventors: Yoshihiro Motomiya, Yoshiyuki Moriguchi, Hiroyuki Ohkawa